CTX-M β-lactamases in Escherichia colifrom community-acquired urinary tract infections, Cambodia

95Citations
Citations of this article
115Readers
Mendeley users who have this article in their library.

Abstract

Despite the recent global spread of CTX-M β-lactamases in Escherichia coli isolates from community-acquired urinary tract infections (CA-UTIs), their dissemination has been little studied in developing countries. In a 2-year prospective study, we documented the prevalence of extended-spectrum β-lactamases (ESBLs) in E. coli that were responsible for CA-UTIs in Phnom-Penh, Cambodia. Ninety-three E. coli strains were included. We observed a high prevalence of resistance to amoxicillin (88.2% of strains), cotrimoxazole (75.3%), ciprofloxacin (67.7%), gentamicin (42.5%), and third-generation cephalosporins (37.7%). A total of 34 strains carried ESBLs, all of which were CTX-M type. CTX-M carriage was associated with resistance to fluoroquinolones and aminoglycosides. Using repetitive extragenic palindromic-PCR, we identified 4 clusters containing 9, 8, 3, and 2 strains. The prevalence of CTX-M β-lactamases has reached a critical level in Cambodia, which highlights the need for study of their spread in developing countries.

Cite

CITATION STYLE

APA

Ruppé, E., Hem, S., Lath, S., Gautier, V., Ariey, F., Sarthou, J. L., … Arlet, G. (2009). CTX-M β-lactamases in Escherichia colifrom community-acquired urinary tract infections, Cambodia. Emerging Infectious Diseases, 15(5), 741–748. https://doi.org/10.3201/eid1505.071299

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free